A. Berroukche, Ely Mohamed-Amine, Mohamed Terras, M. Slimani
{"title":"阿尔及利亚和毛里塔尼亚124例前列腺癌患者的流行病学比较研究","authors":"A. Berroukche, Ely Mohamed-Amine, Mohamed Terras, M. Slimani","doi":"10.6000/1927-7229.2018.07.01.1","DOIUrl":null,"url":null,"abstract":": Prostate cancer (Pca) is a common neoplasia in elderly men. Its incidence increased over the last two decades in the Northern Africa. This study aimed to perform a comparison between epidemiological profiles of Pca in patients from two Maghreb countries (Algeria and Mauritania). This is a retrospective study carried out during 2014- 2016, on population of 124 cases including 64 Pca Algerian patients recorded in the Oncology Department of Saida hospital, the Urology Department of Oran University Hospital and 60 Pca Mauritanians patients recruited in the National Oncology Center and the Friendship Hospital in Nouakchott. For these Pca patiens of different ethnic origin, demographic characteristics were studied and biological monitoring of the tumor marker PSA (prostate specific antigen) was performed in medical biological analysis laboratories using the same methods of serum-PSA assay. The mean age was significantly different in both groups of Pca Algerian and Mauritanian patients (respectively 74 vs 70 years). No significant positive correlation between the age and the PSA, in both groups, was recorded (R = 0.00796 vs R = 0.127) ( p ˃ 0.05 ). The mean serum- PSA levels were 156.5 ± 76.4 ( Pca Algerians) and 179.3 ± 52.1 ng / mL (Pca Mauritanians). Histological evidence was obtained in 54.6 % (Pca Algerians) and 23.3 % (Pca Mauritanian patients). 15 Pca Patients with metastatic tumor stage and 17 cases of death were found. Prostate cancer essentially affects men old over 50 years in both Northern African countries and this comparative study showed the same methods of screening, diagnosis and therapeutic treatment of Pca used in these two areas.","PeriodicalId":14957,"journal":{"name":"Journal of Analytical Oncology","volume":"19 1","pages":"1-7"},"PeriodicalIF":0.0000,"publicationDate":"2018-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparative Epidemiological Profiles in Prostate Cancer Algerian and Mauritanian Patients: Retrospective Study of 124 Cases\",\"authors\":\"A. Berroukche, Ely Mohamed-Amine, Mohamed Terras, M. Slimani\",\"doi\":\"10.6000/1927-7229.2018.07.01.1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\": Prostate cancer (Pca) is a common neoplasia in elderly men. Its incidence increased over the last two decades in the Northern Africa. This study aimed to perform a comparison between epidemiological profiles of Pca in patients from two Maghreb countries (Algeria and Mauritania). This is a retrospective study carried out during 2014- 2016, on population of 124 cases including 64 Pca Algerian patients recorded in the Oncology Department of Saida hospital, the Urology Department of Oran University Hospital and 60 Pca Mauritanians patients recruited in the National Oncology Center and the Friendship Hospital in Nouakchott. For these Pca patiens of different ethnic origin, demographic characteristics were studied and biological monitoring of the tumor marker PSA (prostate specific antigen) was performed in medical biological analysis laboratories using the same methods of serum-PSA assay. The mean age was significantly different in both groups of Pca Algerian and Mauritanian patients (respectively 74 vs 70 years). No significant positive correlation between the age and the PSA, in both groups, was recorded (R = 0.00796 vs R = 0.127) ( p ˃ 0.05 ). The mean serum- PSA levels were 156.5 ± 76.4 ( Pca Algerians) and 179.3 ± 52.1 ng / mL (Pca Mauritanians). Histological evidence was obtained in 54.6 % (Pca Algerians) and 23.3 % (Pca Mauritanian patients). 15 Pca Patients with metastatic tumor stage and 17 cases of death were found. Prostate cancer essentially affects men old over 50 years in both Northern African countries and this comparative study showed the same methods of screening, diagnosis and therapeutic treatment of Pca used in these two areas.\",\"PeriodicalId\":14957,\"journal\":{\"name\":\"Journal of Analytical Oncology\",\"volume\":\"19 1\",\"pages\":\"1-7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Analytical Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.6000/1927-7229.2018.07.01.1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Analytical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6000/1927-7229.2018.07.01.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
前列腺癌(Pca)是老年男性常见的肿瘤。在过去二十年中,其发病率在北非有所增加。本研究旨在比较来自两个马格里布国家(阿尔及利亚和毛里塔尼亚)的Pca患者的流行病学概况。这是一项2014- 2016年对124例患者进行的回顾性研究,其中包括Saida医院肿瘤科、Oran大学医院泌尿外科记录的64例阿尔及利亚Pca患者,以及在努瓦克肖特国家肿瘤中心和友谊医院招募的60例毛里塔尼亚Pca患者。对这些不同种族的前列腺癌患者进行人口统计学特征研究,并在医学生物分析实验室采用与血清PSA检测相同的方法进行肿瘤标志物PSA(前列腺特异性抗原)的生物监测。阿尔及利亚和毛里塔尼亚两组Pca患者的平均年龄有显著差异(分别为74岁和70岁)。两组患者年龄与PSA无显著正相关(R = 0.00796 vs R = 0.127) (p < 0.05)。平均血清PSA水平阿尔及利亚Pca为156.5±76.4 ng / mL,毛里塔尼亚Pca为179.3±52.1 ng / mL。54.6%(阿尔及利亚Pca患者)和23.3%(毛里塔尼亚Pca患者)获得组织学证据。15例Pca患者转移期,17例死亡。在这两个北非国家,前列腺癌主要影响50岁以上的男性,这项比较研究显示,这两个地区使用的前列腺癌筛查、诊断和治疗方法相同。
Comparative Epidemiological Profiles in Prostate Cancer Algerian and Mauritanian Patients: Retrospective Study of 124 Cases
: Prostate cancer (Pca) is a common neoplasia in elderly men. Its incidence increased over the last two decades in the Northern Africa. This study aimed to perform a comparison between epidemiological profiles of Pca in patients from two Maghreb countries (Algeria and Mauritania). This is a retrospective study carried out during 2014- 2016, on population of 124 cases including 64 Pca Algerian patients recorded in the Oncology Department of Saida hospital, the Urology Department of Oran University Hospital and 60 Pca Mauritanians patients recruited in the National Oncology Center and the Friendship Hospital in Nouakchott. For these Pca patiens of different ethnic origin, demographic characteristics were studied and biological monitoring of the tumor marker PSA (prostate specific antigen) was performed in medical biological analysis laboratories using the same methods of serum-PSA assay. The mean age was significantly different in both groups of Pca Algerian and Mauritanian patients (respectively 74 vs 70 years). No significant positive correlation between the age and the PSA, in both groups, was recorded (R = 0.00796 vs R = 0.127) ( p ˃ 0.05 ). The mean serum- PSA levels were 156.5 ± 76.4 ( Pca Algerians) and 179.3 ± 52.1 ng / mL (Pca Mauritanians). Histological evidence was obtained in 54.6 % (Pca Algerians) and 23.3 % (Pca Mauritanian patients). 15 Pca Patients with metastatic tumor stage and 17 cases of death were found. Prostate cancer essentially affects men old over 50 years in both Northern African countries and this comparative study showed the same methods of screening, diagnosis and therapeutic treatment of Pca used in these two areas.